SCHEMBL7908375

SCHEMBL7908375

O=C(C[C@H](NC(=O)C(F)(F)F)C(=O)O)c1ccc(F)c(F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
CHRNA1 P02708 1/20 0.39
CHRNG P07510 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRNB2 P17787 1/20 0.39
SLC6A2 P23975 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CHRND Q07001 1/20 0.39
ITGB2 P05107 1/20 0.37
ICAM1 P05362 1/20 0.37
ITGAL P20701 1/20 0.37
PRSS1 P07477 5/20 0.37
TMPRSS15 P98073 5/20 0.37
ACE P12821 3/20 0.36
ECE1 P42892 1/20 0.36
DPP4 P27487 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7908401 1.00 CES2 (0.40) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL7899386 1.00 CES2 (0.40) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL5889370 0.85 HTT (0.50) PRSS1TMPRSS15MAPTMAPK1RAB9A
SCHEMBL5351455 0.85 HTT (0.50) PRSS1TMPRSS15MAPTMAPK1RAB9A
SCHEMBL5355623 0.85 HTT (0.50) PRSS1TMPRSS15MAPTMAPK1RAB9A
SCHEMBL7799498 0.85 PLOD2 (0.51) ACEKDM4EMAPTRAB9A
SCHEMBL7799493 0.85 PLOD2 (0.51) ACEKDM4EMAPTRAB9A
SCHEMBL7908676 0.83 MAPT (0.43) CES2CES1ITGB2ICAM1ITGAL
SCHEMBL7907206 0.83 KMO (0.56) SLC6A3MAPT
SCHEMBL7899412 0.83 KMO (0.56) SLC6A3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207709-B1 FOR THERAPY AND PROPHYLAXIS OF NEURODEGENERATIVE DISEASES, SUCH AS HUNTINGTON'S CHOREA, ALZHEIMER'S DISEASE, DEMENTIA CAUSED BY AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFARCTUAL DEMENTIA, CEREBRAL ISCHEMIA, CEREBRAL HYPOXIA, EPILEPSY PHARMACIA & UPJOHN S.P.A. (IT) 2001-03-27 US disclosed
EP-0862551-B1 FLUORO-SUBSTITUTED BENZOYLPROPIONIC ACID DERIVATIVES PHARMACIA & UPJOHN SPA (IT) 2000-05-31 EP disclosed
US-5973006-A NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE; HUNTINGTON DISEASE; PARKINSON'S DISEASE PHARMACIA & UPJOHN S.P.A. (IT) 1999-10-26 US disclosed
EP-0931056-A1 N-SUBSTITUTED-2-AMINO-4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITORY ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1999-07-28 EP disclosed
WO-1998009938-A1 N-SUBSTITUTED-2-AMINO-4-PHENYL-4-OXO-BUTANOIC ACID DERIVATIVES WITH KYNURENINE-3-HYDROXYLASE INHIBITORY ACTIVITY PHARMACIA & UPJOHN S.P.A. (IT) 1998-03-12 WO disclosed